4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
Avidity Science(优势品牌)
主营:主营:酶,缓冲剂,酰,生物素克隆和表达系统,AviTag,蛋白质的纯化和鉴定
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Cryopreservation_reagent > 亲和性/BIP300-BIP-300-诱导阳性对照质粒/1/BIP300
商品详细亲和性/BIP300-BIP-300-诱导阳性对照质粒/1/BIP300
亲和性/BIP300-BIP-300-诱导阳性对照质粒/1/BIP300
亲和性/BIP300-BIP-300-诱导阳性对照质粒/1/BIP300
商品编号: BIP300
品牌: Avidity Science
市场价: ¥3000.00
美元价: 2250.00
产地: 美国(厂家直采)
公司:
产品分类: 冻存试剂
公司分类: Cryopreservation_reagent
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍

Product Information

The BIP-300 plasmid allows you to compare your pAN or pAC AviTagTM fusion gene"s protein expression against a confirmed AviTagTM fusion product under the same growth and induction conditions. When transformed into the same E. coli host strain as your own pAN or pAC AviTagTM fusion plasmid construct, and induced in parallel, the BIP-300 Positive Control Plasmid will provide a measure by which to compare your transformation efficiency, growth and antibiotic maintenance conditions, and induction of your plasmid"s gene-fusion construct. The BIP-300 construct consists of a modified β-galactosidase gene (8 amino acids were deleted from its N-terminus) cloned into Avidity"s pAN5 AviTagTM fusion vector at the Multiple Cloning Site. The resulting AviTagTM-protein fusion (AviTag-β-gal), as are all the pAN and pAC fusion products, is under the tight control of the Trc promoter system and expressed upon IPTG induction. The plasmid is maintained with ampicillin. An example induction protocol is given under Protocols. This protocol uses the Avidity AVB101 E. coli strain containing the BirA over-expressing pACYC-184 plasmid construct (pBirAcm) as the host strain. It is initially requires chloramphenicol for maintenance in addition to the ampicillin required to maintain the pAN or pAC plasmid construct. If you are using a different host strain please adjust the protocol accordingly.

Supplied as 1 vial of Positive Control Plasmid DNA; 2µg at 1mg/mL in nuclease-free water (2µL). Store at -20°C.
品牌介绍
亲和生物科学公司是一家私营生物技术公司,是一家开创抗体寡核苷酸结合(AOC)的公司。™)AOCs结合了单克隆抗体的组织选择性和基于寡核苷酸的治疗方法的精确性,以克服寡核苷酸传递的障碍和疾病的目标遗传驱动因素。它们的AOC平台,演示了疾病相关RNA在细胞类型和组织中的调节,包括肌肉、心脏、肝脏、肿瘤和免疫细胞。专有的平台技术可以在单一抗体支架上传递多种治疗性寡核苷酸。AOCs具有类似于抗体的药物性质,并允许将寡核苷酸有效载荷传递到其他运载平台所不提供的非肝组织。AOC也有其独特之处,因为可以处理不可药物的目标。 它们正在推进一系列的治疗计划,重点是罕见的肌肉疾病和其他严重疾病。主要项目是开发治疗杜氏肌营养不良和肌营养不良患者的治疗方法。还与制药合作伙伴合作开展项目。并得到了经验丰富的团队和受人尊敬的生命科学投资者的支持。